Pages that link to "Q45789942"
Jump to navigation
Jump to search
The following pages link to Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease (Q45789942):
Displaying 50 items.
- Untangling tau imaging (Q26739091) (← links)
- Insight into the Molecular Imaging of Alzheimer's Disease (Q26768635) (← links)
- Characteristics of Tau and Its Ligands in PET Imaging (Q26769952) (← links)
- Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE (Q26781672) (← links)
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 (Q26801629) (← links)
- Imaging pathological tau in atypical parkinsonian disorders (Q26823039) (← links)
- Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging (Q27020981) (← links)
- Spreading of pathology in neurodegenerative diseases: a focus on human studies (Q28082279) (← links)
- Key emerging issues in progressive supranuclear palsy and corticobasal degeneration (Q28084976) (← links)
- High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection (Q28241366) (← links)
- Tau imaging: early progress and future directions (Q28253740) (← links)
- Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex (Q30100986) (← links)
- Imaging frontotemporal lobar degeneration (Q30846573) (← links)
- Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy (Q30996799) (← links)
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. (Q31063014) (← links)
- Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807 (Q33795224) (← links)
- Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography (Q34378321) (← links)
- Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process? (Q34445601) (← links)
- Molecular imaging of Alzheimer disease pathology (Q34651135) (← links)
- Tau PET imaging: present and future directions (Q34680852) (← links)
- The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. (Q34989647) (← links)
- Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography. (Q35804873) (← links)
- Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue (Q35810005) (← links)
- Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351 (Q36064072) (← links)
- The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations (Q36165011) (← links)
- Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils. (Q36218847) (← links)
- PET Radioligands for Imaging of Tau Pathology: Current Status (Q36241261) (← links)
- Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease (Q36298335) (← links)
- Tau imaging in neurodegenerative diseases (Q36834567) (← links)
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain (Q37096041) (← links)
- Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs (Q37256805) (← links)
- Highly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer's Disease (Q37298615) (← links)
- [18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation. (Q37577889) (← links)
- Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition (Q37739881) (← links)
- Biomarker modelling of early molecular changes in Alzheimer's disease (Q38166669) (← links)
- Alzheimer's disease and other dementias: advances in 2013. (Q38170692) (← links)
- In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals (Q38195938) (← links)
- Imaging of cerebrovascular pathology in animal models of Alzheimer's disease (Q38198632) (← links)
- Tau PET imaging in Alzheimer's disease (Q38252750) (← links)
- Clinical workout for the early detection of cognitive decline and dementia (Q38255755) (← links)
- Invited review: Drug development for tauopathies (Q38263698) (← links)
- Developments in Tau PET Imaging (Q38271405) (← links)
- Cell-based Models To Investigate Tau Aggregation (Q38287992) (← links)
- In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. (Q38436447) (← links)
- Biomarkers in Sporadic and Familial Alzheimer's Disease (Q38592041) (← links)
- Tau and neurodegenerative disease: the story so far. (Q38658752) (← links)
- Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives (Q38719665) (← links)
- Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology (Q38821003) (← links)
- Molecular and cellular pathophysiology of preclinical Alzheimer's disease (Q38836004) (← links)
- Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET. (Q38902474) (← links)